The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2025
Synopsis
Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thick and sticky mucus. The disease develops over a period of time in the lungs and blocks the tubes that carry air in and out. Increased secretion of thick mucus accelerates the growth of bacteria and hence, gives rise to serious lung infections. Some of the major symptoms of cystic fibrosis include persistent cough, constant lung infection, salty tasting skin, problem in breathing, bulky stools, difficulty in bowel movements, poor growth and poor weight gain. Some of the tests available for cystic fibrosis are newborn screening, sweat test, chest x-ray, lung function tests, and genetic testing. Cystic fibrosis can be divided into three segments, namely, cystic fibrosis mutations, curable type of cystic fibrosis, and rare type of cystic fibrosis. Some of the treatment methods for cystic fibrosis are chest physical therapy (CPT), exercise, consumption of antibiotics, lung transplant and postural drainage.
The global Cystic Fibrosis (Mucoviscoidosis) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Major driving factors for the growth of the cystic fibrosis market are increasing number of patients suffering from cystic fibrosis, rising need and demand for sophisticated testing tools, and increased government funding for the development of genetic testing. Moreover, every company wants to grow and develop by using pharmacogenomic diagnostic tools, so that they have an enviable position in the existing market. Rapid adoption of potentially advanced tests to diagnose cystic fibrosis and increasing awareness and affordability of the people across geographies will continually provide growth towards this market. On the other hand, factors like huge amount of capital involved and few adverse effects like pulmonary exacerbations and weight gain would most likely impede the growth of this market.
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis (Mucoviscoidosis) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis (Mucoviscoidosis) Testing.
Report Scope
The Cystic Fibrosis (Mucoviscoidosis) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cystic Fibrosis (Mucoviscoidosis) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cystic Fibrosis (Mucoviscoidosis) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Vertex Pharmaceuticals
Abbott
Pfizer
NovaBiotics
Cystic Fibrosis Foundation
Galapagos
Segment by Type
Chest Physical Therapy (CPT)
Consumption Of Antibiotics
Lung Transplant And Postural Drainage
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis (Mucoviscoidosis) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thick and sticky mucus. The disease develops over a period of time in the lungs and blocks the tubes that carry air in and out. Increased secretion of thick mucus accelerates the growth of bacteria and hence, gives rise to serious lung infections. Some of the major symptoms of cystic fibrosis include persistent cough, constant lung infection, salty tasting skin, problem in breathing, bulky stools, difficulty in bowel movements, poor growth and poor weight gain. Some of the tests available for cystic fibrosis are newborn screening, sweat test, chest x-ray, lung function tests, and genetic testing. Cystic fibrosis can be divided into three segments, namely, cystic fibrosis mutations, curable type of cystic fibrosis, and rare type of cystic fibrosis. Some of the treatment methods for cystic fibrosis are chest physical therapy (CPT), exercise, consumption of antibiotics, lung transplant and postural drainage.
The global Cystic Fibrosis (Mucoviscoidosis) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Major driving factors for the growth of the cystic fibrosis market are increasing number of patients suffering from cystic fibrosis, rising need and demand for sophisticated testing tools, and increased government funding for the development of genetic testing. Moreover, every company wants to grow and develop by using pharmacogenomic diagnostic tools, so that they have an enviable position in the existing market. Rapid adoption of potentially advanced tests to diagnose cystic fibrosis and increasing awareness and affordability of the people across geographies will continually provide growth towards this market. On the other hand, factors like huge amount of capital involved and few adverse effects like pulmonary exacerbations and weight gain would most likely impede the growth of this market.
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis (Mucoviscoidosis) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis (Mucoviscoidosis) Testing.
Report Scope
The Cystic Fibrosis (Mucoviscoidosis) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cystic Fibrosis (Mucoviscoidosis) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cystic Fibrosis (Mucoviscoidosis) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Vertex Pharmaceuticals
Abbott
Pfizer
NovaBiotics
Cystic Fibrosis Foundation
Galapagos
Segment by Type
Chest Physical Therapy (CPT)
Consumption Of Antibiotics
Lung Transplant And Postural Drainage
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis (Mucoviscoidosis) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chest Physical Therapy (CPT)
1.2.3 Consumption Of Antibiotics
1.2.4 Lung Transplant And Postural Drainage
1.3 Market by Application
1.3.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Perspective (2019-2030)
2.2 Cystic Fibrosis (Mucoviscoidosis) Testing Growth Trends by Region
2.2.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cystic Fibrosis (Mucoviscoidosis) Testing Historic Market Size by Region (2019-2024)
2.2.3 Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Region (2025-2030)
2.3 Cystic Fibrosis (Mucoviscoidosis) Testing Market Dynamics
2.3.1 Cystic Fibrosis (Mucoviscoidosis) Testing Industry Trends
2.3.2 Cystic Fibrosis (Mucoviscoidosis) Testing Market Drivers
2.3.3 Cystic Fibrosis (Mucoviscoidosis) Testing Market Challenges
2.3.4 Cystic Fibrosis (Mucoviscoidosis) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis (Mucoviscoidosis) Testing Players by Revenue
3.1.1 Global Top Cystic Fibrosis (Mucoviscoidosis) Testing Players by Revenue (2019-2024)
3.1.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cystic Fibrosis (Mucoviscoidosis) Testing Revenue
3.4 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Concentration Ratio
3.4.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis (Mucoviscoidosis) Testing Revenue in 2023
3.5 Cystic Fibrosis (Mucoviscoidosis) Testing Key Players Head office and Area Served
3.6 Key Players Cystic Fibrosis (Mucoviscoidosis) Testing Product Solution and Service
3.7 Date of Enter into Cystic Fibrosis (Mucoviscoidosis) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cystic Fibrosis (Mucoviscoidosis) Testing Breakdown Data by Type
4.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Historic Market Size by Type (2019-2024)
4.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Type (2025-2030)
5 Cystic Fibrosis (Mucoviscoidosis) Testing Breakdown Data by Application
5.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Historic Market Size by Application (2019-2024)
5.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (2019-2030)
6.2 North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024)
6.4 North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (2019-2030)
7.2 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024)
7.4 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (2019-2030)
8.2 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (2019-2030)
9.2 Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024)
9.4 Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (2019-2030)
10.2 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Detail
11.1.2 Vertex Pharmaceuticals Business Overview
11.1.3 Vertex Pharmaceuticals Cystic Fibrosis (Mucoviscoidosis) Testing Introduction
11.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
11.1.5 Vertex Pharmaceuticals Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Cystic Fibrosis (Mucoviscoidosis) Testing Introduction
11.2.4 Abbott Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cystic Fibrosis (Mucoviscoidosis) Testing Introduction
11.3.4 Pfizer Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 NovaBiotics
11.4.1 NovaBiotics Company Detail
11.4.2 NovaBiotics Business Overview
11.4.3 NovaBiotics Cystic Fibrosis (Mucoviscoidosis) Testing Introduction
11.4.4 NovaBiotics Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
11.4.5 NovaBiotics Recent Development
11.5 Cystic Fibrosis Foundation
11.5.1 Cystic Fibrosis Foundation Company Detail
11.5.2 Cystic Fibrosis Foundation Business Overview
11.5.3 Cystic Fibrosis Foundation Cystic Fibrosis (Mucoviscoidosis) Testing Introduction
11.5.4 Cystic Fibrosis Foundation Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
11.5.5 Cystic Fibrosis Foundation Recent Development
11.6 Galapagos
11.6.1 Galapagos Company Detail
11.6.2 Galapagos Business Overview
11.6.3 Galapagos Cystic Fibrosis (Mucoviscoidosis) Testing Introduction
11.6.4 Galapagos Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
11.6.5 Galapagos Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chest Physical Therapy (CPT)
Table 3. Key Players of Consumption Of Antibiotics
Table 4. Key Players of Lung Transplant And Postural Drainage
Table 5. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Region (2019-2024)
Table 9. Global Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Region (2025-2030)
Table 11. Cystic Fibrosis (Mucoviscoidosis) Testing Market Trends
Table 12. Cystic Fibrosis (Mucoviscoidosis) Testing Market Drivers
Table 13. Cystic Fibrosis (Mucoviscoidosis) Testing Market Challenges
Table 14. Cystic Fibrosis (Mucoviscoidosis) Testing Market Restraints
Table 15. Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Players (2019-2024)
Table 17. Global Top Cystic Fibrosis (Mucoviscoidosis) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing as of 2023)
Table 18. Ranking of Global Top Cystic Fibrosis (Mucoviscoidosis) Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Cystic Fibrosis (Mucoviscoidosis) Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cystic Fibrosis (Mucoviscoidosis) Testing Product Solution and Service
Table 22. Date of Enter into Cystic Fibrosis (Mucoviscoidosis) Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue Market Share by Application (2019-2024)
Table 30. Global Cystic Fibrosis (Mucoviscoidosis) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue Market Share by Application (2025-2030)
Table 32. North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Vertex Pharmaceuticals Company Detail
Table 48. Vertex Pharmaceuticals Business Overview
Table 49. Vertex Pharmaceuticals Cystic Fibrosis (Mucoviscoidosis) Testing Product
Table 50. Vertex Pharmaceuticals Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)
Table 51. Vertex Pharmaceuticals Recent Development
Table 52. Abbott Company Detail
Table 53. Abbott Business Overview
Table 54. Abbott Cystic Fibrosis (Mucoviscoidosis) Testing Product
Table 55. Abbott Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)
Table 56. Abbott Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Cystic Fibrosis (Mucoviscoidosis) Testing Product
Table 60. Pfizer Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. NovaBiotics Company Detail
Table 63. NovaBiotics Business Overview
Table 64. NovaBiotics Cystic Fibrosis (Mucoviscoidosis) Testing Product
Table 65. NovaBiotics Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)
Table 66. NovaBiotics Recent Development
Table 67. Cystic Fibrosis Foundation Company Detail
Table 68. Cystic Fibrosis Foundation Business Overview
Table 69. Cystic Fibrosis Foundation Cystic Fibrosis (Mucoviscoidosis) Testing Product
Table 70. Cystic Fibrosis Foundation Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)
Table 71. Cystic Fibrosis Foundation Recent Development
Table 72. Galapagos Company Detail
Table 73. Galapagos Business Overview
Table 74. Galapagos Cystic Fibrosis (Mucoviscoidosis) Testing Product
Table 75. Galapagos Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024) & (US$ Million)
Table 76. Galapagos Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Type: 2023 VS 2030
Figure 3. Chest Physical Therapy (CPT) Features
Figure 4. Consumption Of Antibiotics Features
Figure 5. Lung Transplant And Postural Drainage Features
Figure 6. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Cystic Fibrosis (Mucoviscoidosis) Testing Report Years Considered
Figure 12. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Region: 2023 VS 2030
Figure 15. Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Players in 2023
Figure 16. Global Top Cystic Fibrosis (Mucoviscoidosis) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (Mucoviscoidosis) Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Cystic Fibrosis (Mucoviscoidosis) Testing Revenue in 2023
Figure 18. North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Country (2019-2030)
Figure 20. United States Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Country (2019-2030)
Figure 24. Germany Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Region (2019-2030)
Figure 32. China Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Country (2019-2030)
Figure 40. Mexico Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Share by Country (2019-2030)
Figure 44. Turkey Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
Figure 47. Abbott Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
Figure 49. NovaBiotics Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
Figure 50. Cystic Fibrosis Foundation Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
Figure 51. Galapagos Revenue Growth Rate in Cystic Fibrosis (Mucoviscoidosis) Testing Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
